A detailed history of Black Rock Inc. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,299,991 shares of AXSM stock, worth $287 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,299,991
Previous 3,195,490 3.27%
Holding current value
$287 Million
Previous $255 Million 4.18%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$65.72 - $80.5 $6.87 Million - $8.41 Million
104,501 Added 3.27%
3,299,991 $266 Million
Q1 2024

May 10, 2024

SELL
$69.39 - $97.64 $3.07 Million - $4.32 Million
-44,256 Reduced 1.37%
3,195,490 $255 Million
Q4 2023

Feb 13, 2024

BUY
$57.42 - $83.61 $17.5 Million - $25.5 Million
305,256 Added 10.4%
3,239,746 $258 Million
Q3 2023

Nov 13, 2023

BUY
$69.25 - $82.21 $14.6 Million - $17.3 Million
210,947 Added 7.75%
2,934,490 $205 Million
Q2 2023

Aug 11, 2023

BUY
$58.41 - $90.35 $14.9 Million - $23.1 Million
255,319 Added 10.34%
2,723,543 $196 Million
Q1 2023

May 12, 2023

SELL
$58.39 - $75.0 $2.03 Million - $2.61 Million
-34,753 Reduced 1.39%
2,468,224 $152 Million
Q4 2022

Feb 13, 2023

BUY
$39.94 - $79.72 $12.4 Million - $24.8 Million
310,722 Added 14.17%
2,502,977 $193 Million
Q3 2022

Nov 14, 2022

SELL
$36.06 - $69.85 $1.33 Million - $2.57 Million
-36,822 Reduced 1.65%
2,192,255 $97.8 Million
Q2 2022

Aug 12, 2022

BUY
$21.74 - $46.75 $2.97 Million - $6.4 Million
136,820 Added 6.54%
2,229,077 $85.4 Million
Q1 2022

May 12, 2022

SELL
$23.7 - $41.39 $411,550 - $718,737
-17,365 Reduced 0.82%
2,092,257 $86.6 Million
Q4 2021

Feb 10, 2022

BUY
$30.7 - $43.36 $1.28 Million - $1.8 Million
41,559 Added 2.01%
2,109,622 $79.7 Million
Q3 2021

Nov 09, 2021

SELL
$19.91 - $68.26 $1.05 Million - $3.6 Million
-52,691 Reduced 2.48%
2,068,063 $68.2 Million
Q2 2021

Aug 11, 2021

BUY
$50.63 - $73.5 $107 Million - $156 Million
2,120,754 New
2,120,754 $143 Million

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.73B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.